Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments

Astrocytes orchestrate neural development by powerfully coordinating synapse formation and function and, as such, may be critically involved in the pathogenesis of neurodevelopmental abnormalities and cognitive deficits commonly observed in psychiatric disorders. Here, we report the identification of a subset of cortical astrocytes that are competent for regulating dopamine (DA) homeostasis during postnatal development of the prefrontal cortex (PFC), allowing for optimal DA-mediated maturation of excitatory circuits. Such control of DA homeostasis occurs through the coordinated activity of astroglial vesicular monoamine transporter 2 (VMAT2) together with organic cation transporter 3 and monoamine oxidase type B, two key proteins for DA uptake and metabolism. Conditional deletion of VMAT2 in astrocytes postnatally produces loss of PFC DA homeostasis, leading to defective synaptic transmission and plasticity as well as impaired executive functions. Our findings show a novel role for PFC astrocytes in the DA modulation of cognitive performances with relevance to psychiatric disorders.

[1]  Frank W. Pfrieger,et al.  Synaptic Integration of Adult-Born Hippocampal Neurons Is Locally Controlled by Astrocytes , 2015, Neuron.

[2]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[3]  A. Koleske.  Molecular mechanisms of dendrite stability , 2013, Nature Reviews Neuroscience.

[4]  G. Šimić,et al.  Extraordinary neoteny of synaptic spines in the human prefrontal cortex , 2011, Proceedings of the National Academy of Sciences.

[5]  Heinz Bönisch,et al.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.

[6]  R. Edwards,et al.  Fast Subplasma Membrane Ca2+ Transients Control Exo-Endocytosis of Synaptic-Like Microvesicles in Astrocytes , 2008, The Journal of Neuroscience.

[7]  M. Jung,et al.  Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression , 2015, Nature Neuroscience.

[8]  E. Pothos,et al.  Vesicular Transport Regulates Monoamine Storage and Release but Is Not Essential for Amphetamine Action , 1997, Neuron.

[9]  F. Kirchhoff,et al.  Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen‐inducible DNA recombinase variant CreERT2 , 2006, Glia.

[10]  S. Sesack,et al.  Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. , 1998, Cerebral cortex.

[11]  E. Kandel,et al.  Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning , 2006, Neuron.

[12]  S. Hyman.  Perspective: Revealing molecular secrets , 2014, Nature.

[13]  M. D’Esposito,et al.  Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control , 2011, Biological Psychiatry.

[14]  E. Miller,et al.  An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.

[15]  M. Caron,et al.  Dopamine: from pharmacology to molecular biology and back , 2006, Wiener klinische Wochenschrift.

[16]  A. Peters,et al.  The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines. , 1970, The American journal of anatomy.

[17]  Kuei Y Tseng,et al.  Dopamine–Glutamate Interactions Controlling Prefrontal Cortical Pyramidal Cell Excitability Involve Multiple Signaling Mechanisms , 2004, The Journal of Neuroscience.

[18]  Kyu-Hee Lee,et al.  Endocytosis of somatodendritic NCKX2 is regulated by Src family kinase-dependent tyrosine phosphorylation , 2013, Front. Cell. Neurosci..

[19]  T. Hasegawa,et al.  The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats , 2007, Brain Research.

[20]  J. Storm-Mathisen,et al.  Immunogold quantification of amino acids and proteins in complex subcellular compartments , 2008, Nature Protocols.

[21]  D. Schubert,et al.  Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders , 2014, Molecular Psychiatry.

[22]  B. Sabatini,et al.  Neuromodulation of excitatory synaptogenesis in striatal development , 2015, eLife.

[23]  V. Parpura,et al.  Homer1 Scaffold Proteins Govern Ca2+ Dynamics in Normal and Reactive Astrocytes , 2017, Cerebral cortex.

[24]  S. Oliet,et al.  Gliotransmitters Travel in Time and Space , 2014, Neuron.

[25]  Lief E. Fenno,et al.  Neocortical excitation/inhibition balance in information processing and social dysfunction , 2011, Nature.

[26]  Ben A. Barres,et al.  Emerging roles of astrocytes in neural circuit development , 2013, Nature Reviews Neuroscience.

[27]  David H Rowitch,et al.  Astrocytes and disease: a neurodevelopmental perspective. , 2012, Genes & development.

[28]  B. Giros,et al.  Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain , 2006, Neuropharmacology.

[29]  P. Bezzi,et al.  Novel insights into gliotransmitters. , 2016, Current opinion in pharmacology.

[30]  M. Poo,et al.  Phasic dopamine release in the medial prefrontal cortex enhances stimulus discrimination , 2016, Proceedings of the National Academy of Sciences.

[31]  R. Edwards.  The Neurotransmitter Cycle and Quantal Size , 2007, Neuron.

[32]  E. Richfield,et al.  Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system , 1989, Neuroscience.

[33]  A. Diamond.  Consequences of variations in genes that affect dopamine in prefrontal cortex. , 2007, Cerebral cortex.

[34]  A. Giuffrida,et al.  Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-801 , 2009, Behavioural Brain Research.

[35]  B. Giros,et al.  Altered aminergic neurotransmission in the brain of organic cation transporter 3‐deficient mice , 2008, Journal of neurochemistry.

[36]  Amy E. Shyer,et al.  A Glial Variant of the Vesicular Monoamine Transporter Is Required To Store Histamine in the Drosophila Visual System , 2008, PLoS genetics.

[37]  Nicola J. Allen,et al.  Neuroscience: Glia — more than just brain glue , 2009, Nature.

[38]  E. Pehek,et al.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat , 2002, Brain Research.

[39]  N. Ballatori,et al.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway , 2009, Proceedings of the National Academy of Sciences.

[40]  D. Attwell,et al.  Do astrocytes really exocytose neurotransmitters? , 2010, Nature Reviews Neuroscience.

[41]  G. Bonvento,et al.  Engineered lentiviral vector targeting astrocytes In vivo , 2009, Glia.

[42]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[43]  K. Abid,et al.  High-throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate. , 2013, Analytical chemistry.

[44]  Graeme Eisenhofer,et al.  Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine , 2004, Pharmacological Reviews.

[45]  V. Gradinaru,et al.  Dopaminergic dysfunction in neurodevelopmental disorders: recent advances and synergistic technologies to aid basic research , 2018, Current Opinion in Neurobiology.

[46]  Zheng Li,et al.  Age–dependent regulation of synaptic connections by dopamine D2 receptors , 2013, Nature Neuroscience.

[47]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[48]  Y. Goto,et al.  Prefrontal cortical dopamine from an evolutionary perspective , 2015, Neuroscience Bulletin.

[49]  Thomas F. Nugent,et al.  Dynamic mapping of human cortical development during childhood through early adulthood. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Gavin Rumbaugh,et al.  Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses , 2012, Cell.

[51]  P. Penzes,et al.  Dendritic spine pathology in neuropsychiatric disorders , 2011, Nature Neuroscience.

[52]  B. Hoffman,et al.  Expression cloning of a reserpine-sensitive vesicular monoamine transporter. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Denys,et al.  Dopaminergic control of cognitive flexibility in humans and animals , 2013, Front. Neurosci..

[54]  D. Grandy,et al.  Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamine D1 and D2 but not D4 receptor knockout mice , 2009, Brain Research.

[55]  R. Elliott,et al.  Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease. , 2013, Journal of neuropsychology.

[56]  J. Raber,et al.  A role for glia in the progression of Rett’s syndrome , 2011, Nature.

[57]  Jie Qin,et al.  Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice , 2005, Nature Neuroscience.

[58]  G. Feng,et al.  Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP , 2000, Neuron.

[59]  C. Lowry,et al.  Distribution of organic cation transporter 3, a corticosterone‐sensitive monoamine transporter, in the rat brain , 2009, The Journal of comparative neurology.

[60]  Kelly R. Tan,et al.  GABA Neurons of the VTA Drive Conditioned Place Aversion , 2012, Neuron.

[61]  M. Karayiorgou,et al.  Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice , 2010, Journal of neurochemistry.

[62]  Carlo Sala,et al.  Dendritic spines: the locus of structural and functional plasticity. , 2014, Physiological reviews.

[63]  A. Verkhratsky,et al.  Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion , 2016, The EMBO journal.

[64]  Frank Kirchhoff,et al.  Expression of reef coral fluorescent proteins in the central nervous system of transgenic mice , 2005, Molecular and Cellular Neuroscience.

[65]  P. Gaspar,et al.  Severe Serotonin Depletion after Conditional Deletion of the Vesicular Monoamine Transporter 2 Gene in Serotonin Neurons: Neural and Behavioral Consequences , 2011, Neuropsychopharmacology.

[66]  Joanne Wang,et al.  Identification and Characterization of a Novel Monoamine Transporter in the Human Brain* , 2004, Journal of Biological Chemistry.

[67]  B. Sabatini,et al.  Dopaminergic Modulation of Synaptic Transmission in Cortex and Striatum , 2012, Neuron.

[68]  D. Sulzer,et al.  Intracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells , 2003, The Journal of Neuroscience.

[69]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[70]  P. O’Donnell,et al.  Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  Bin Xu,et al.  Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex , 2011, Proceedings of the National Academy of Sciences.

[72]  V. Gundersen,et al.  Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate , 2004, Nature Neuroscience.

[73]  T. Yoshikawa,et al.  Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma‐derived cell line , 2014, Journal of neurochemistry.

[74]  J. Meldolesi,et al.  Astrocytes, from brain glue to communication elements: the revolution continues , 2005, Nature Reviews Neuroscience.

[75]  G. Carmignoto,et al.  Astrocyte control of synaptic transmission and neurovascular coupling. , 2006, Physiological reviews.

[76]  Keith F. Tipton,et al.  The therapeutic potential of monoamine oxidase inhibitors , 2006, Nature Reviews Neuroscience.

[77]  C. Lüscher,et al.  SHANK3 controls maturation of social reward circuits in the VTA , 2016, Nature Neuroscience.

[78]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[79]  B. Giros,et al.  Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation , 2004, The Journal of Neuroscience.

[80]  K. Deisseroth,et al.  Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning , 2009, Science.

[81]  Brenda J Butka.  Imaging , 2003, JAMA.

[82]  R. Wightman,et al.  Catecholamine release and uptake in the mouse prefrontal cortex , 2001, Journal of neurochemistry.

[83]  H. Sasano,et al.  Molecular mechanism of histamine clearance by primary human astrocytes , 2013, Glia.

[84]  J. O. Schenk,et al.  Characterization of Extracellular Dopamine Clearance in the Medial Prefrontal Cortex: Role of Monoamine Uptake and Monoamine Oxidase Inhibition , 2001, The Journal of Neuroscience.

[85]  A. Volterra,et al.  A neuron–glia signalling network in the active brain , 2001, Current Opinion in Neurobiology.

[86]  Fei Xu,et al.  Knockout of the Vesicular Monoamine Transporter 2 Gene Results in Neonatal Death and Supersensitivity to Cocaine and Amphetamine , 1997, Neuron.

[87]  G. Stanwood,et al.  Developmental origins of brain disorders: roles for dopamine , 2013, Front. Cell. Neurosci..